首页> 外国专利> 5'-phosphorothiolate mRNA 5'-terminal (cap) analogs, mRNAs containing them, methods for obtaining them and methods for their use

5'-phosphorothiolate mRNA 5'-terminal (cap) analogs, mRNAs containing them, methods for obtaining them and methods for their use

机译:5'-硫代磷酸硫酯mRNA 5'-末端(帽)类似物,包含它们的mRNA,获得它们的方法及其使用方法

摘要

The present invention relates to nucleotide, mRNA 5'-terminal (cap) analogs containing a sulfur atom at the 5 'position of 7-methylguanosine nucleoside. The disclosed compounds are recognized by the DcpS enzyme (decapping scavenger) (binding and non-hydrolyzing) and thus therapeutic uses as inhibitors thereof can be discovered. DcpS is a cap-specific enzyme with pyrophosphatase activity that has been identified as a therapeutic target in the treatment of spinal muscular atrophy (SMA). Some of the disclosed compounds have further modifications in the phosphate chain, which modulates the affinity for the DcpS enzyme. The present invention further relates to mRNA modified with a 5'-end (cap) analog at the 5 'end containing a 5'-phosphorothiolate moiety, wherein the mRNA has increased stability and translational activity in the cellular state. And the present invention relates to methods for their preparation, their use, and pharmaceutical formulations containing them. [Selection]
机译:本发明涉及在7-甲基鸟苷核苷的5'位置含有硫原子的核苷酸mRNA 5'-末端(cap)类似物。所公开的化合物被DcpS酶(去壳清除剂)识别(结合和非水解),因此可以发现作为其抑制剂的治疗用途。 DcpS是一种具有焦磷酸酶活性的帽特异性酶,已被确定为治疗脊髓性肌萎缩症(SMA)的治疗靶标。一些公开的化合物在磷酸酯链中具有进一步的修饰,其调节了对DcpS酶的亲和力。本发明进一步涉及在5'端用5'-末端(cap)类似物修饰的mRNA,其含有5'-硫代磷酸酯部分,其中mRNA在细胞状态下具有增加的稳定性和翻译活性。本发明涉及其制备方法,用途和包含它们的药物制剂。 [选择]

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号